Among several antigens including CD19, CD138 and SLAMF7, B-cell maturation antigen (BCMA) represents the most promising to date due to its high selective expression on normal plasma and MM cells (82, 83). The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.